This summary notes some of the lessons learnt from the HepCATT (Hepatitis C Assessment Through to Treatment)
Randomised Controlled Trial.
HepCATT tested an Hepatitis C virus (HCV) case-finding intervention in primary care. The intervention
involved:
• Algorithm integrated into electronic patient records systems to identify high risk patients
• Automatic mail-merge to create letters to invite high risk patients for testing
• Pop-ups alerts in patient records to encourage opportunistic testing
• Practice Staff HCV educational training
Resources
Commissioner
NHS England, CCGs and local authorities are all responsible for commissioning different parts of hepatitis C testing, treatment and care. Find here tools, templates and other relevant documents to assist commissioners with their responsibilities to ensure hepatitis C patients are diagnosed and receive high quality care.
Showing 81 to 90 of 398 resources
-
Lessons learnt from HepCATT for ODNs and GP practices
UK, England Training, Tools & Templates, Strategy & Planning PDF -
Good practice case study: Pop-up hepatitis C testing for people in supported accommodation during the COVID-19 outbreak
During the COVID-19 pandemic, the ‘Everyone In’ policy meant that people who would otherwise be homeless were given accommodation in hotels. Surrey Operational Delivery Network, like many other ODNs, used this as an opportunity to engage with this cohort, offering testing and treatment for hepatitis C. This case study details how the team from Royal Surrey County Hospital and The Hepatitis C Trust were able to test people in these hotels and other forms of accommodation.UK, England, South East Case study, Strategy & Planning PDF -
Good practice case study: Hepatitis C care for homeless individuals in Slough
This good practice case study, produced by the Turning Point substance misuse service, highlights recent work carried out by nurse and hepatitis C champion Fay Smith in collaboration with colleagues. With previously-homeless individuals accommodated following the Covid-19 outbreak, the opportunity was seized to offer hepatitis C testing and treatment to this cohort.South East 17 Aug 2020 Case study PDF -
Summary Report: Hepatitis C services in Scotland during and beyond the Covid-19 outbreak - August 2020
With the Covid-19 outbreak having caused significant disruption to health services in Scotland, including those for hepatitis C, as well as drug and alcohol services, HCV Action organised a webinar to discuss how services and the drive to elimination in Scotland have been affected. This report provides a summary of the remarks from each of the four speakers and the Q&A which followed.Scotland Case study, Reports & Research, Tools & Templates, Strategy & Planning PDF -
HCV Action webinar: Hepatitis C services in Scotland during and beyond Covid-19
With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, this webinar was organised to discuss how services have been affected in Scotland and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. The webinar featured contributions from the following speakers: Professor John Dillon - Clinical Lead for Blood Borne Viruses, NHS Tayside Leon Wylie - Lead Officer, Hepatitis Scotland Rachel Halford - CEO, The Hepatitis C TrustScotland 05 Aug 2020 Training, Tools & Templates, Strategy & Planning Video -
Summary report: Hepatitis C services during and beyond Covid-19 webinar - June 2020
With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, HCV Action organised a webinar to discuss how services have been affected in different areas across the country and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. This report provides a summary of the remarks from each of the four speakers and the Q&A which followed.England 24 Jun 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF -
HCV Action webinar: Hepatitis C services during and beyond Covid-19
With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, this webinar was organised to discuss how services have been affected in different areas across England and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. The webinar featured contributions from the following speakers: • Mark Gillyon-Powell - Head of Programme, HCV Elimination, NHS England & NHS Improvement • Dr Steve Ryder - Chair, HCV Action and Clinical Lead, Nottingham Hepatitis C ODNEngland 22 Jun 2020 Training, Strategy & Planning Video -
Public Health England Hepatitis C in England 2020 Report
Public Health England published its annual 'Hepatitis C in England' report on 30th May 2020. This reporting document monitors the England's progress towards its goal of eliminating the virus by 2030 and contains breakdowns of how testing and treatment are being delivered by service type, demographic and local area. This year's report notes significant increases in treatment availability over the last few years. It also suggests there have been increases in access to treatment for the people who inject drugs.England Reports & Research PDF -
Drug-related infectious diseases in Europe: Update from the EMCDDA expert network, 2020
This 2020 update on drug-related infectious diseases from the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020. It highlights some recent innovative responses to the problem and argues that early diagnosis through testing as well as improving links to treatment and care are crucial steps towards reaching global health goals.UK, Rest of World Reports & Research, Strategy & Planning PDF -
Guidance on Contingency Planning for People who use Drugs and COVID-19: Version 2.0
This Scottish Drugs Forum-produced guidance is aimed at those planning and designing services as well as those managing and delivering services for people who use drugs, in particular those people on opioid substitution therapy (OST) and people who inject drugs. The guidance includes a section on blood borne virus (BBV) testing, noting that "all delayed BBV results from dry blood spot tests must be proactively followed up in a timely manner once COVID-19 related restrictions allow".Scotland 13 May 2020 Tools & Templates, Strategy & Planning PDF